Projects per year
Fingerprint
Dive into the research topics where Janice Mehnert is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
Promoting Bim-driven apoptosis through MAPK inhibition: A therapeutic strategy in advanced melanoma
Mehnert, J., MEHNERT, J., Sullivan, R. & Sullivan, R.
12/8/15 → 11/30/21
Project: Research project
-
CANCER CENTER SUPPORT GRANT
Kane, M., Zong, W., Mehnert, J., Manne, S., Delnevo, C., Shen, Z., Ganesan, S., Foran, D., Liu, C., Laskin, D., Shih, W., Aisner, J., Lattime, E., Haffty, B., Bertino, J., August, D., Goodin, S., Goodin, S., August, D., Laskin, D., Shih, W., Rabinowitz, J., Zheng, S., Sant'Angelo, D. B., Tanzer, L. L., Gallo, J., Leibowitz, M., Chin, K. V., Ravikumar, T., Hait, W., Dipaola, R., Libutti, S. K., Kinzy, T. G., Spaulding, H., Amenta, P., Denicola, G., Shen, M. M., Kinzy, T. G., Notterman, D., Amenta, P. S., Rubin, E. H., Cunningham, R. S. & Saunders, T.
3/1/97 → 2/29/24
Project: Research project
-
Wisconsin and New Jersey Alliance in Precision Experimental Therapeutics
DiPaola, R. S., Mehnert, J., Dipaola, R., Liu, G., Liu, G., Liu, G., Jabbour, S. & Liu, G.
3/19/14 → 2/28/21
Project: Research project
-
A Phase 0 Trial of Hydroxychloroquine in Patients with Stage III and IV Resectabl
Mehnert, J. & MEHNERT, J.
7/7/10 → 6/30/13
Project: Research project
Research output
-
A multicenter characterization of hepatitis associated with immune checkpoint inhibitors
Patrinely, J. R., McGuigan, B., Chandra, S., Fenton, S. E., Chowdhary, A., Kennedy, L. B., Mooradian, M. J., Palmeri, M., Portal, D., Horst, S. N., Scoville, E. A., Long, G. V., Shi, C., Mehnert, J. M., Sullivan, R. J., Salama, A. K., Sosman, J. A., Menzies, A. M. & Johnson, D. B., 2021, In: OncoImmunology. 10, 1, 1875639.Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma
Kangas-Dick, A. W., Greenbaum, A., Gall, V., Groisberg, R., Mehnert, J., Chen, C., Moore, D. F., Berger, A. C. & Koshenkov, V., 2021, (Accepted/In press) In: Annals of Surgical Oncology.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors
Stein, M. N., Goodin, S., Gounder, M., Gibbon, D., Moss, R., Portal, D., Lindquist, D., Zhao, Y., Takebe, N., Tan, A., Aisner, J., Lin, H., Ready, N. & Mehnert, J. M., Jun 1 2020, In: Investigational New Drugs. 38, 3, p. 855-865 11 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: Long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial
D'Angelo, S. P., Bhatia, S., Brohl, A. S., Hamid, O., Mehnert, J. M., Terheyden, P., Shih, K. C., Brownell, I., Lebbé, C., Lewis, K. D., Linette, G. P., Milella, M., Georges, S., Shah, P., Ellers-Lenz, B., Bajars, M., Güzel, G. & Nghiem, P. T., May 15 2020, In: Journal for ImmunoTherapy of Cancer. 8, 1, e000674.Research output: Contribution to journal › Article › peer-review
Open Access16 Scopus citations -
Biomarkers for Response to Immune Checkpoint Blockade
Ganesan, S. & Mehnert, J., Mar 4 2020, In: Annual Review of Cancer Biology. 4, p. 331-351 21 p.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations